Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study to Evaluate the Efficacy of Neuraminidase Inhibitor Treatment in ST-Elevation Myocardial Infarction (STEMI) Patients

NCT04684498 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT04684498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04684498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study to Evaluate the Efficacy of Neuraminidase Inhibitor Treatment in ST-Elevation Myocardial Infarction (STEMI) Patients
Lead sponsor
Tongji Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2020
Completion date
March 31, 2024
Enrollment
382 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

st elevation myocardial infarction, stemi